Welcome to LookChem.com Sign In|Join Free
  • or
1H-Benzimidazole,2-pyrazinyl-(9CI), also known as 2-(pyrazin-2-yl)-1H-benzimidazole (Hpbi), is a versatile ligand capable of forming supramolecular complexes with cadmium(II) salts, exhibiting distinct structural architectures (1D chains, binuclear, or mononuclear complexes) depending on the anion used (Cl-, Br-, or I-). These complexes demonstrate intermolecular hydrogen bonding and π-π stacking interactions, forming 3D supramolecular frameworks. The ligand's coordination mode remains consistent across complexes, with anion size influencing both structural geometry and luminescent properties. Additionally, derivatives of this scaffold, such as 2-pbmq, have been explored in copper complexes for anticancer applications, where structural modifications (e.g., triphenylphosphine introduction) enhance cytotoxicity and biological activity. The core benzimidazole-pyrazine structure also exhibits strong fluorescence in certain derivatives, suggesting potential utility in sensing applications.

2602-88-2

Post Buying Request

2602-88-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2602-88-2 Usage

Heterocyclic compound

It contains both carbon and nitrogen atoms in its ring structures, making it a heterocyclic compound.

Benzimidazole ring

The compound has a benzimidazole ring, which is a fused system of a benzene ring and an imidazole ring.

Pyrazine ring

The compound also has a pyrazine ring, which is a six-membered heterocyclic ring consisting of two pyridine rings connected by a single carbon atom.

Pharmaceutical intermediate

1H-Benzimidazole,2-pyrazinyl-(9CI) has potential applications as a pharmaceutical intermediate, meaning it can be used in the synthesis of various biologically active compounds.

Biologically active compounds

It may be used in the synthesis of compounds with potential therapeutic effects.

Health and environmental hazards

1H-Benzimidazole,2-pyrazinyl-(9CI) should be handled with care, as it may pose health and environmental risks.

Variable properties and uses

The exact properties and potential uses of 1H-Benzimidazole,2-pyrazinyl-(9CI) can vary depending on the specific derivative or form in which it is utilized.

Check Digit Verification of cas no

The CAS Registry Mumber 2602-88-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,0 and 2 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2602-88:
(6*2)+(5*6)+(4*0)+(3*2)+(2*8)+(1*8)=72
72 % 10 = 2
So 2602-88-2 is a valid CAS Registry Number.

2602-88-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-pyrazin-2-yl-1H-benzimidazole

1.2 Other means of identification

Product number -
Other names (benzimidazol-2-yl)pyrazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2602-88-2 SDS

2602-88-2Downstream Products

2602-88-2Relevant academic research and scientific papers

Effect of anions on cadmium(II) complexes with ligand 2-(pyrazin-2-yl)-1H- benzimidazole

Wang, Yong-Tao,Yan, Shi-Chen,Tang, Gui-Mei,Zhao, Chao,Li, Tian-Duo,Cui, Yue-Zhi

, p. 492 - 499 (2011)

Three new supramolecular complexes based on a 2-(pyrazin-2-yl)-1H- benzimidazole (Hpbi) and a series of Cd(II) salts have been solvothermally synthesized and structurally characterized by single-crystal X-ray diffraction analysis. Reaction of CdCl2·2.5H2O with Hpbi afforded a one-dimensional chain [Cd(Hpbi)Cl2] (1), which exhibits a three-dimensional (3-D) supramolecular architecture through intermolecular X-H?Cl (X = N and C) hydrogen bonds and π-π stacking interactions. When using CdBr2·4H2O instead of CdCl 2·2.5H2O under similar reaction conditions, a bisnuclear complex [Cd(Hpbi)2Br2] (2) is obtained, which obviously exhibits intermolecular X-H?Br (X = N and C) hydrogen bonds and π-π stacking interactions. When CdI2 take place of CdCl 2·2.5H2O, a mononuclear complex, [Cd(Hpbi) 2I2] (3), is isolated, which shows a 3D supramolecule framework formed by intermolecule hydrogen bonds and π-π packing interactions. Interestingly, the Hpbi ligand exhibits the same coordination modes in complexes 1-3. It is noteworthy that the radius of anions plays an important role in affecting the structures and luminescent intensity of the final products. The TGA for 1-3 have been investigated and discussed in detail.

Influence of the introduction of a triphenylphosphine group on the anticancer activity of a copper complex

Gan, Ning,Guo, Yan,Hou, Hongwei,Hu, Jiyong,Li, Sen,Mei, Yameng,Yuan, Bangpeng,Zhang, Junshuai,Zhao, Jin'an

, (2020)

Aiming at obtaining new copper complexes with good cytotoxicity against cancer cells, triphenylphosphine (TPP) was introduced to obtain insight into the influence of the co-ligands. In this paper, two copper complexes, Cu(2-pbmq)(CH3OH)Br2 (1) and [Cu(2-pbmq)(TPP)Br]2 (2) were designed, synthesized, and characterized by X-ray crystallography, 2-((2-(pyrazin-2-yl)-1H-benzo[d]imidazol-1-yl)methyl))quinolone (2-pbmq), to investigate the influence of the TPP group on the anticancer activity of the metal complex. Although the presence of the TPP group diminished the intensity of the interaction properties of the complex with DNA, the in vitro anticancer activity and cellular uptake of the TPP-containing complex were markedly superior to those of its TPP-lacking counterpart. Detailed studies on the more potently cytotoxic complex 2 revealed that it accumulated in nucleus, arrested the cell cycle at the G0-G1 phase, causing mitochondrial dysfunction, involving the potential simultaneous mitochondrial membrane collapse, cellular ATP level depletion, and Ca2+ leakage, eventually inducing cell apoptosis. In summary, the introduction of a TPP group enhances the biological activity and cytotoxicity of the complex.

Synthesis and spectroscopic properties of 2,5-bis(benzoazol-2-yl)pyrazines

Saito, Ryota,Machida, Shinnosuke,Suzuki, Saori,Katoh, Akira

, p. 531 - 536 (2008)

A class of π-conjugated 2,5-bis(benzoazol-2-yl)pyrazine dyes have been synthesized in which 2,5-bis(benzimidazol-2-yl)pyrazine (1) exhibits strong fluorescence in solution. The enhanced fluorescence of 1 with a base leads to future applications such as anion sensing feasible upon chemical modification.

I2/TBHP promoted oxidative C–N bond formation at room temperature: Divergent access of 2-substituted benzimidazoles involving ring distortion

Saha, Moumita,Das, Asish R.

supporting information, p. 2520 - 2525 (2018/05/31)

A new ‘one pot’ tandem synthesis of 2-substituted benzimidazoles has been developed from 2-aminobenzyl alcohol/2-aminobenzamide and different coupling partners (nitriles, aldehydes and 1,3-diketones) via iodine and TBHP promoted oxidative ring contraction. The present strategy involves sequential C–N bond formation, cyclization, subsequent ring contraction and dehydrogenation to afford various medicinally important benzimidazole derivatives in moderate to good yields. This operationally simple synthetic approach proceeds at room temperature under base-free condition, broadly applicable to a wide array of nitriles and aldehydes bearing oxidation prone functional groups and noteworthy to mention that various acyclic 1,3-diketones undergo selective C–C bond cleavage leading to 2-alkyl benzimidazoles under mild condition.

Metal-mediated inhibition of escherichia coli methionine aminopeptidase: Structure-activity relationships and development of a novel scoring function for metal-ligand interactions

Schiffmann, Rolf,Neugebauer, Alexander,Klein, Christian D.

, p. 511 - 522 (2007/10/03)

We report the discovery of thiabendazole as a potent inhibitor (K 1 = 0.4 μM) of Escherichia coli methionine aminopeptidase (ecMetAP) and the synthesis and pharmacological evaluation of thiabendazole congeners with activity in the upper nanomolar range, Elucidation of the X-ray structure of ecMetAP in complex with thiabendazole and an unrelated inhibitor that was independently described by another group showed that that both compounds bind to an additional CoII ion at the entrance of the active site. This unexpected finding explains the inactivity of the compounds under in vivo conditions. It also allows us to discuss the structure-activity relationships of this series of compounds in a meaningful way, based upon docking runs with an auxiliary metal ion, We describe a new scoring function for the evaluation of metal-mediated inhibitor binding that, unlike the previously used scoring function implemented in the docking program, allows us to distinguish between active and inactive compounds, Finally, conclusions for the structure-based design of in vivo-active inhibitors of ecMetAP are drawn.

Microwave-assisted synthesis of aryl and heteroaryl derivatives of benzimidazole

Yu, Haitao,Kawanishi, Hirohisa,Koshima, Hideko

, p. 1457 - 1460 (2007/10/03)

A series of benzimidazoles containing aryl and heteroaryl substituents were efficiently and quickly synthesized by condensation of 1,2phenylenediamine with carboxylic acids in the presence of polyphosphoric acid under microwave irradiation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2602-88-2